[
  {
    "ts": null,
    "headline": "Wall Street Lunch: Ghost Of Stagflation Alarms Investors",
    "summary": "The stagflation specter is spooking traders today, wiping out the risk-on move that was buoying stocks and weighing on board following the weekend surge in crypto.",
    "url": "https://finnhub.io/api/news?id=0f2ff858b9d36ccef7c905b89ca723267377cf787a012acd0bd3ede993ae83af",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741009860,
      "headline": "Wall Street Lunch: Ghost Of Stagflation Alarms Investors",
      "id": 132955746,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/171293890/image_171293890.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "The stagflation specter is spooking traders today, wiping out the risk-on move that was buoying stocks and weighing on board following the weekend surge in crypto.",
      "url": "https://finnhub.io/api/news?id=0f2ff858b9d36ccef7c905b89ca723267377cf787a012acd0bd3ede993ae83af"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson's DARZALEX subcutaneous-based regimen receives positive CHMP opinion for patients with newly diagnosed multiple myeloma, regardless of transplant eligibility",
    "summary": "BEERSE, BELGIUM - Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has...",
    "url": "https://finnhub.io/api/news?id=40eb3aa139f0dc9abafbb33acd7fa8752d450d627b40c40f32cf86eaca9c1d01",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740999560,
      "headline": "Johnson & Johnson's DARZALEX subcutaneous-based regimen receives positive CHMP opinion for patients with newly diagnosed multiple myeloma, regardless of transplant eligibility",
      "id": 132954286,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "BEERSE, BELGIUM - Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has...",
      "url": "https://finnhub.io/api/news?id=40eb3aa139f0dc9abafbb33acd7fa8752d450d627b40c40f32cf86eaca9c1d01"
    }
  }
]